Plain-English translation of NCT02795052 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called bone marrow-derived stem cell (BMSC) therapy for people with nervous system diseases like Parkinson's, ALS, Alzheimer's, stroke, or traumatic brain injury. The stem cells are collected from your own bone marrow, then put back into your body through an IV and applied inside your nose to help repair nerve damage. Researchers believe these cells may help restore function that has been lost.
Many nervous system diseases cause permanent damage that current medicines and surgeries cannot reverse. Early research suggests that stem cell therapy may help repair this damage and improve function, but doctors need to test this treatment in more patients to understand how well it works and whether it's safe.
You likely qualify if…
You likely don't qualify if…
If you join this trial, doctors will take a small sample of bone marrow from your hip bone. The stem cells will be separated and prepared, then given back to you through an IV injection and also applied topically inside your lower nasal passages. You will need to come back for follow-up nerve function tests and exams with the study doctors or your own neurologist to see if the treatment helps your symptoms. The exact number of visits and duration depends on your specific condition, but you should be prepared for ongoing monitoring after your treatment.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States
United Arab Emirates